Nature Communications (Oct 2020)

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies

  • Edurne Rujas,
  • Hong Cui,
  • Taylor Sicard,
  • Anthony Semesi,
  • Jean-Philippe Julien

DOI
https://doi.org/10.1038/s41467-020-18828-4
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 11

Abstract

Read online

The inducible co-stimulator (ICOS) is a member of the CD28/B7 superfamily, binding its ligand (ICOS-L) on activated T cells. The structure of the ICOS/ICOS-L complex reveals a distinct receptor binding orientation. The structures of ICOS and ICOS-L in complex with potentially therapeutic antibodies suggest the structural basis of such antibodies’ efficacies and high binding affinities.